Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1477-1486

  Mapel, Douglas W ^a   Dalal, Anand A ^b   Johnson, Phaedra T ^c   Becker, Laura K ^c   Hunter, Alyssa Goolsby ^c  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Life Sciences Optum   (United States)

Author keywords

Assessment; Comorbidity; Exacerbation; Global initiative for chronic obstructive lung disease; Spirometry; Stratification

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY ASSESSMENT; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE STAGING SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; RESPIRATORY TRACT DISEASE ASSESSMENT; SELF EVALUATION; SELF REPORT; SPIROMETRY; UNITED STATES; VERY ELDERLY; ATTITUDE TO HEALTH; CLASSIFICATION; CLINICAL TRIAL; DISEASE COURSE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; LUNG; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG; MALE; MIDDLE AGED; PATIENTS; PHYSICIANS, PRIMARY CARE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84938401813     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S78827     Document Type: Article

References (35)

1. Fletcher CM. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press; 1976.
2. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983;128(3):491–500.
3. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982–994.
4. Jones PW, Anderson JA, Calverley PM, et al. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res. 2011;12:71.
5. Weatherall M, Marsh S, Shirtcliffe P, Williams M, Travers J, Beasley R. Quality of life measured by the St George’s Respiratory Questionnaire and spirometry. Eur Respir J. 2009;33(5):1025–1030.
6. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:435–444.
7. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.
8. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709.
9. Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011;12:40.
10. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–268.
11. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137–148.
12. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988–1994 to 2007–2010. Chest. 2013;143(5):1395–1406.
13. Rennard SI, Vestbo J, Agusti A. What is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometry. Am J Respir Crit Care Med. 2013;187(10):1036–1037.
14. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654.
15. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
16. goldcopd.org [homepage on the Internet]. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014 GOLD COPD Committee. Available from: http://www.goldcopd.org/. Accessed December 6, 2014.
17. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)–why and what? Clin Respir J. 2012;6(4):208–214.
18. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–981.
19. Johannessen A, Nilsen RM, Storebo M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. 2013;188(1):51–59.
20. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43–50.
21. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest. 2013;143(3):694–702.
22. Kim S, Oh J, Kim YI, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med. 2013;13:35.
23. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647–654.
24. Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129–135.
25. Casanova C, Marin JM, Martinez-Gonzalez C, et al. New GOLD classification: longitudinal data on group assignment. Respir Res. 2014;15:3.
26. de Torres JP, Marin JM, Martinez-Gonzalez C, et al. Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort. Chest. 2014;146(1):111–122.
27. de Torres JP, Casanova C, Marin JM, et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax. 2014;69(9):799–804.
28. Rieger-Reyes C, Garcia-Tirado FJ, Rubio-Galan FJ, Marin-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new Global Initiative for Chronic Obstructive Lung Disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale. Arch Bronconeumol. 2014;50(4):129–134.
29. Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis. 2014;9:551–561.
30. Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L. The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J. 2014;43(4):993–1002.
31. Gruffydd-Jones K. GOLD guidelines 2011: what are the implications for primary care? Prim Care Respir J. 2012;21(4):437–441.
32. Mapel DW, Dalal AA, Johnson P, Becker L, Goolsby Hunter A. A Clinical Study of COPD Severity Assessment by Primary Care Physicians and their Patients as Compared to Spirometry. Am J Med. Epub 2015 Jan 13.
33. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187.
34. Gravetter FJF, Lori-Ann B. Research Methods for the Behavioral Sciences, 4th Edition. Belmont, CA: Wadsworth; 2012.
35. Lloyd H, Jenkinson C, Hadi M, Gibbons E, Fitzpatrick R. Patient reports of the outcomes of treatment: a structured review of approaches. Health Qual Life Outcomes. 2014;12:5.